Systemic Delivery of 134.5-Deleted Herpes Simplex Virus-1 Selectively Targets and Treats Distant Human Xenograft Tumors That Express High MEK Activity
Cancer Research - United States
doi 10.1158/0008-5472.can-07-1499
Full Text
Open PDFAbstract
Available in full text
Date
September 1, 2007
Authors
Publisher
American Association for Cancer Research (AACR)